An intron 7 polymorphism in APP affects the age of onset of dementia in down syndrome

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Jones, Emma L ^a   Ballard, Clive G ^a   Prasher, Vee P ^a   Arno, Matthew ^a   Tyrer, Stephen ^b   Moore, Brian ^b   Hanney, Maria Luisa ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c Northgate Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; APP GENE; ARTICLE; DOWN SYNDROME; FEMALE; GENE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; ONSET AGE; PRIORITY JOURNAL;

EID: 79251591920     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/929102     Document Type: Article

References (28)

1. Hook E. B., Rates and Down's syndrome in live births and at midtrimester amniocentesis Lancet 1978 1 8072 1053 1054
2. Wisniewski H. M., Silverman W., Wegiel J., Ageing, Alzheimer disease and mental retardation Journal of Intellectual Disability Research 1994 38 3 233 239
3. Terry R. D., Hansen L. A., DeTeresa R., Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles Journal of Neuropathology and Experimental Neurology 1987 46 3 262 268
4. Prasher V. P., Krishnan V. H. R., Age of onset and duration of dementia in people with Down syndrome: integration of 98 reported cases in the literature International Journal of Geriatric Psychiatry 1993 8 11 915 922
5. Holland A. J., Hon J., Huppert F. A., Stevens F., Watson P., Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome British Journal of Psychiatry 1998 172 493 498
6. Rumble B., Retallack R., Hilbich C., Simms G., Multhaup G., Martins R., Hockey A., Montgomery P., Beyreuther K., Masters C. L., Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease New England Journal of Medicine 1989 320 22 1446 1452 (Pubitemid 19143709)
7. Rovelet-Lecrux A., Hannequin D., Raux G., Le Meur N., Laquerrire A., Vital A., Dumanchin C., Feuillette S., Brice A., Vercelletto M., Dubas F., Frebourg T., Campion D., APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy Nature Genetics 2006 38 1 24 26
8. Sleegers K., Brouwers N., Gijselinck I., Theuns J., Goossens D., Wauters J., Del-Favero J., Cruts M., Van Duijn C. M., Van Broeckhoven C., APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy Brain 2006 129 11 2977 2983
9. Cabrejo L., Guyant-Marchal L., Laquerrire A., Vercelletto M., De La Fournire F., Thomas-Antrion C., Verny C., Letournel F., Pasquier F., Vital A., Checler F., Frebourg T., Campion D., Hannequin D., Phenotype associated with APP duplication in five families Brain 2006 129 11 2966 2976
10. Kasuga K., Shimohata T., Nishimura A., Shiga A., Mizuguchi T., Tokunaga J., Ohno T., Miyashita A., Kuwano R., Matsumoto N., Onodera O., Nishizawa M., Ikeuchi T., Identification of independent APP locus duplication in Japanese patients with early-onset Alzheimer disease Journal of Neurology, Neurosurgery and Psychiatry 2009 80 9 1050 1052
11. Beyreuther K., Pollwein P., Multhaup G., Monning U., Konig G., Dyrks T., Schubert W., Masters C. L., Regulation and expression of the Alzheimer's /A4 amyloid protein precursor in health, disease, and Down's syndrome Annals of the New York Academy of Sciences 1993 695 91 102
12. Wolvetang E. W., Bradfield O. M., Tymms M., Zavarsek S., Hatzistavrou T., Kola I., Hertzog P. J., The chromosome 21 transcription factor ETS2 transactivates the -APP promoter: implications for Down syndrome Biochimica et Biophysica Acta-Gene Structure and Expression 2003 1628 2 105 110
13. Tanzi R. E., McClatchey A. I., Lamperti E. D., Villa-Komaroff L., Gusella J. F., Neve R. L., Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease Nature 1988 331 6156 528 530
14. Matsui T., Ingelsson M., Fukumoto H., Ramasamy K., Kowa H., Frosch M. P., Irizarry M. C., Hyman B. T., Expression of APP pathway mRNAs and proteins in Alzheimer's disease Brain Research 2007 1161 1 116 123
15. Johnson S. A., McNeill T., Cordell B., Finch C. B., Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease Science 1990 248 4957 854 857
16. Higgins L. S., Catalano R., Quon D., Cordell B., Transgenic mice expressing human -APP751, but not mice expressing -APP695, display early Alzheimer's disease-like histopathology Annals of the New York Academy of Sciences 1993 695 224 227
17. Li L., Perry R., Wu J., Pham D., Ohman T., Harrell L. E., Go R. C. P., Fukuchi K. I., Polymorphic tetranucleotide repeat site within intron 7 of the -amyloid precursor protein gene and its lack of association with Alzheimer's disease Human Genetics 1998 103 1 86 89
18. Margallo-Lana M., Morris C. M., Gibson A. M., Tan A. L., Kay D. W. K., Tyrer S. P., Moore B. P., Ballard C. G., Influence of the amyloid precursor protein locus on dementia in Down syndrome Neurology 2004 62 11 1996 1998
19. Prasher V., Farooq A., Holder R., The Adaptive Behaviour Dementia Questionnaire (ABDQ): screening questionnaire for dementia in Alzheimer's disease in adults with Down syndrome Research in Developmental Disabilities 2004 25 4 385 397
20. World Health Organisation, International Classification of Diseases 1992 10th Geneva, Switzerland WHO
21. Donev R., Newall A., Thome J., Sheer D., A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms Molecular Psychiatry 2007 12 7 681 690
22. Haiman C. A., Hankinson S. E., Spiegelman D., De Vivo I., Colditz G. A., Willett W. C., Speizer F. E., Hunter D. J., A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk International Journal of Cancer 2000 87 2 204 210 (Pubitemid 30434346)
23. Shiroeda H., Tahara T., Shibata T., Nakamura M., Yamada H., Nomura T., Hayashi R., Saito T., Fukuyama T., Otsuka T., Yano H., Ozaki K., Tsuchishima M., Tsutsumi M., Arisawa T., Functional promoter polymorphisms of macrophage migration inhibitory factor in peptic ulcer diseases International Journal of Molecular Medicine 2010 26 5 707 711
24. Barrachina M., Dalf E., Puig B., Vidal N., Freixes M., Castao E., Ferrer I., Amyloid- deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in A PP mRNA isoforms containing the Kunitz protease inhibitor Neurochemistry International 2005 46 3 253 260
25. Caswell M. D., Mok SU. S., Henry A., Cappai R., Klug G., Beyreuther K., Masters C. L., Small D. H., The amyloid -protein precursor of Alzheimer's disease is degraded extracellularly by a Kunitz protease inhibitor domain-sensitive trypsin-like serine protease in cultures of chick sympathetic neurons European Journal of Biochemistry 1999 266 2 509 516
26. Moir R. D., Tanzi R. E., LRP-mediated clearance of A is inhibited by KPI-containing isoforms of APP Current Alzheimer Research 2005 2 2 269 273
27. Van Broeckhoven C., Backhovens H., Cruts M., Martin J. J., Crook R., Houlden H., Hardy J., APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease Neuroscience Letters 1994 169 1-2 179 180
28. Lewis H., Beher D., Cookson N., Oakley A., Piggott M., Morris C. M., Jaros E., Perry R., Ince P., Kenny R. A., Ballard C. G., Shearman M. S., Kalaria R. N., Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid- (42) peptide in vascular dementia Neuropathology and Applied Neurobiology 2006 32 2 103 118